Detaillierte Beitrags-Information

Zurück zur Liste

Beitragstitel Assessment patient reported outcomes in sarcoma patients undergoing a diagnostic imaging guided biopsy
Beitragscode P70
  1. Philip Heesen Swiss Sarcoma Network. Kantonsspital Luzern, Kantonsspital Winterthur Vortragender
  2. Georg Schelling Luzerner Kantonsspital & Swiss Sarcoma Network
  3. Carlo Theus-Steinmann Articon Spezialpraxis für Gelenkchirurgie
  4. Bruno Fuchs Luzerner Kantonsspital & Swiss Sarcoma Network
Präsentationsform Poster
  • A09 - Qualitätssicherung
Abstract Introduction
The imaging guided biopsy of a musculoskeletal tumor is a critical step to establish the diagnosis before treatment initiation. Because this represents an invasive procedure, patients must be informed thoroughly about the purpose and the potential side effects including pain. Health-related outcome measure are becoming more and more important specifically in the context of determining the quality of therapy and value-based health care. To the best of the authors’ knowledge, there is no patient related outcome measure defined for the diagnostic work-up of sarcoma-patients.

We developed a questionnaire for patients undergoing an imaging guided biopsy for a suspected sarcoma. Ten questions focused on the understanding of the purpose, about their feeling of the biopsy procedure, the pain level, and the organization of the biopsy as well as the act itself, and post procedure control. Each of the 13 questions was scored with 0 to 10 points directly on an iPad.

A total of 64 patients were evaluated with this biopsy related outcome measure by the patients. 98% of all patients understood the purpose for the biopsy, and they felt well informed. Pain level experienced during the biopsy varied from 0 to 10, as was expected by them, but the level of pain was judged by 75% of patients as 3 out of 10 and lower. There were no local wound problems in the aftermath of the biopsy.

The assessment of patient reported outcome and experience measures undergoing an imaging guided biopsy for the suspicion of a soft tissue sarcoma is feasible. The initial analysis reveals that overall patient satisfaction level is high. Further analysis focuses on detailed scores with respect to the type of diagnosis, location of the tumor as well as demographic parameters.